Improvement in Ulcerative Colitis by Administration of Benralizumab for Comorbid Refractory Bronchial Asthma: A Novel Clinical Observation

Inflamm Bowel Dis. 2021 Jan 1;27(1):e3-e4. doi: 10.1093/ibd/izaa225.

Authors

Affiliations

¹ The First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
² Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
³ Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Japan.
⁴ Department of Endoscopic and Photodynamic Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

PMID: 32812020
DOI: 10.1093/ibd/izaa225

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anti-Asthmatic Agents / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Asthma / drug therapy*
Colitis, Ulcerative / drug therapy*
Humans
Male
Medical Illustration
Treatment Outcome

Substances

Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
benralizumab